Atlas Trials

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Clinical trial NCT06099769 · RECRUITING

Trial details

NCT number
NCT06099769
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2023-10-18
Primary completion
2027-10-01
Enrollment
201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.